CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $49,999,983
- in 2 filings
- Open-market sales, last 90 days
- $215,781
- in 9 filings
Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 41 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-27 | Hill Stephen J. Chief Operating Officer | Grant or award · Option (right to buy) | +75,000 | 75,000 | ||
| 2025-10-27 | Seely Lynn President and CEO | Grant or award · Option (right to buy) | +175,000 | 175,000 | ||
| 2025-08-21 | Seely Lynn President and CEO | Sale | −7,257 | $10.54 | $77K | 67,571 |
| 2025-08-21 | Hill Stephen J. Chief Operating Officer | Sale | −1,004 | $10.54 | $11K | 15,845 |
| 2025-08-21 | Newton Charles W. Chief Financial Officer | Sale | −1,453 | $10.54 | $15K | 15,306 |
| 2025-08-21 | Lee Gary K. Chief Scientific Officer | Sale | −1,453 | $10.54 | $15K | 15,504 |
| 2025-08-20 | Seely Lynn President and CEO | Grant or award | +40,000 | 74,828 | ||
| 2025-08-20 | Hill Stephen J. Chief Operating Officer | Grant or award | +8,000 | 16,849 | ||
| 2025-08-20 | Newton Charles W. Chief Financial Officer | Grant or award | +8,000 | 16,759 | ||
| 2025-08-20 | Lee Gary K. Chief Scientific Officer | Grant or award | +8,000 | 16,957 | ||
| 2025-08-12 | Seely Lynn President and CEO | Sale | −406 | $10.34 | $4K | 34,828 |
| 2025-08-12 | Hill Stephen J. Chief Operating Officer | Sale | −94 | $10.34 | $972 | 8,849 |
| 2025-08-12 | Lee Gary K. Chief Scientific Officer | Sale | −136 | $10.34 | $1K | 8,957 |
| 2025-08-12 | Newton Charles W. Chief Financial Officer | Sale | −136 | $10.34 | $1K | 8,759 |
| 2025-08-11 | Seely Lynn President and CEO | Sale | −391 | $10.53 | $4K | 35,234 |
| 2025-08-11 | Hill Stephen J. Chief Operating Officer | Sale | −91 | $10.53 | $958 | 8,943 |
| 2025-08-11 | Lee Gary K. Chief Scientific Officer | Sale | −131 | $10.53 | $1K | 9,093 |
| 2025-08-11 | Newton Charles W. Chief Financial Officer | Sale | −131 | $10.53 | $1K | 8,895 |
| 2025-06-09 | Bachleda Mark Director | Grant or award · Option (right to buy) | +13,000 | 13,000 | ||
| 2025-06-09 | Meltz Mark A General Counsel | Grant or award · Option (right to buy) | +100,000 | 100,000 |
Page 4 of 8 · 156 trades